Mostrando 1 - 3 Resultados de 3 Para Buscar 'M.R. Cooperberg', tiempo de consulta: 0.02s Limitar resultados
  1. 1
    Defining intermediate-risk prostate cancer suitable for active surveillance with PSA 10-20ng/ml: Pathological outcome analysis of a population-level dataset

    Defining intermediate-risk prostate cancer suitable for active surveillance with PSA 10-20ng/ml: Pathological outcome analysis of a population-level dataset por P.E. Lonergan, C.W. Jeong, S.L. Washington, A. Herlemann, P.R. Carroll, M.R. Cooperberg

    Publicado 2020-07-01
    Enlace del recurso
    Artículo
  2. 2
    Risk factors which predict biopsy upgrading over time in active surveillance for prostate cancer

    Risk factors which predict biopsy upgrading over time in active surveillance for prostate cancer por P.E. Lonergan, S.L. Washington, S. Zhao, J.E. Cowan, H.G. Nguyen, K. Shinohara, M.R. Cooperberg, P.R. Carroll

    Publicado 2020-07-01
    Enlace del recurso
    Artículo
  3. 3
    Clinical utility of 4Kscore, ExosomeDx and SelectMDx and magnetic resonance imaging for the early detection of high-grade prostate cancer

    Clinical utility of 4Kscore, ExosomeDx and SelectMDx and magnetic resonance imaging for the early detection of high-grade prostate cancer por V. Fasulo, C.M. De la Calle, J.E. Cowan, P.E. Lonergan, M. Maggi, A.J. Gadzinsky, R.A. Yeoung, A. Saita, G. Lughezzani, R. Hurle, P. Casale, M.R. Cooperberg, K. Shinohara, P.R. Carroll, H.G. Nguyen

    Publicado 2020-10-01
    Enlace del recurso
    Artículo

Herramientas de búsqueda: